HuMAB companies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who started this subject	9/28/2000 1:01:38 PM
From: nigel bates	Read Replies (1) of 1022

Sept. 28 /PRNewswire/ -- Eos Biotechnology, Inc. today announced the completion of a $27.5 million private placement of preferred stock. Funds raised in this round of financing will be used to further expand Eos' genomics-based technologies and databases, and to develop the Company's antibody therapeutics. Participants in the private placement included existing investors and a number of new investors. Eos' corporate collaborators, Affymetrix, Biogen, and Medarex, participated in this investment round... ....Eos has already established collaborations with Affymetrix, Inc. for the development and manufacturing of GeneChip® DNA Arrays; with Medarex, Inc. for the development of fully human antibodies directed against genome-derived targets for treating certain cancers; with Biogen, Inc. for the development of therapeutic products to treat breast cancer; and with Aventis-Pasteur for genome-derived targets against which to develop cancer vaccines. Further information about Eos and its programs is available at eosbiotech.com. They look a bit like a mini HGSI. Noticed this one as the old BIL fund (now 3i Bioscience) holds stock. nig

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next